Država: Velika Britanija
Jezik: angleščina
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Desogestrel; Ethinylestradiol
Organon Pharma (UK) Ltd
G03AA09
Desogestrel; Ethinylestradiol
150microgram ; 30microgram
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 07030100; GTIN: 5013257000513
PACKAGE LEAFLET: INFORMATION FOR THE USER MARVELON® desogestrel (150 micrograms) ethinyl estradiol (30 micrograms) IMPORTANT THINGS TO KNOW ABOUT COMBINED HORMONAL CONTRACEPTIVES (CHCS): • They are one of the most reliable reversible methods of contraception if used correctly. • They slightly increase the risk of having a blood clot in the veins and arteries, especially in the first year or when restarting a combined hormonal contraceptive following a break of 4 or more weeks. • Please be alert and see your doctor if you think you may have symptoms of a blood clot (see section 2 “Blood clots”). • Some women should not take the Pill because of current medical problems or illnesses. Please read this leaflet to make sure Marvelon is right for you. • To prevent pregnancy it is important to take Marvelon as instructed and to start each pack on time. Please make sure that you understand what to do if you miss a pill or if you think you are pregnant. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions or need more advice, ask your doctor, family planning nurse or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, family planning nurse or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. WHAT MARVELON IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU USE MARVELON 3. HOW TO TAKE MARVELON 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE MARVELON 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT MARVELON IS AND WHAT IT IS USED FOR Marvelon is a combined oral contraceptive pill (‘the Pill’). YOU TAKE IT TO PREVENT PREGNANCY. This low-dose contraceptive contains two types of female sex hormones, oestro Preberite celoten dokument
OBJECT 1 MARVELON TABLETS Summary of Product Characteristics Updated 25-Apr-2022 | Organon Pharma (UK) Limited • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Marvelon® 2. Qualitative and quantitative composition Desogestrel B.P. 150 micrograms Ethinylestradiol Ph.Eur 30 micrograms Excipient with known effect: lactose. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Tablets. Tablets are round, biconvex and 6 mm in diameter. They are coded on one side TR5 and on the reverse side Organon*. 4. Clinical particulars 4.1 Therapeutic indications Oral contraception. The decision to prescribe Marvelon should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Marvelon compares with other CHCs (see sections 4.3 and 4.4). 4.2 Posology and method of administration 4.2.1 HOW TO TAKE MARVELON Tablets must be taken in the order directed on the package every day at about the Preberite celoten dokument